# ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)

> **NCT05894538** · PHASE3 · COMPLETED · sponsor: **Susanna Naggie, MD** · enrollment: 1459 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Ivermectin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05894538
- **Lead sponsor:** Susanna Naggie, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-16
- **Primary completion:** 2022-08-29
- **Final completion:** 2022-10-30
- **Target enrollment:** 1459 (ACTUAL)
- **Last updated:** 2023-11-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05894538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05894538, "ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05894538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*